1. Home
  2. KLXE vs CUE Comparison

KLXE vs CUE Comparison

Compare KLXE & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • CUE
  • Stock Information
  • Founded
  • KLXE 2018
  • CUE 2014
  • Country
  • KLXE United States
  • CUE United States
  • Employees
  • KLXE N/A
  • CUE N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • CUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • CUE Health Care
  • Exchange
  • KLXE Nasdaq
  • CUE Nasdaq
  • Market Cap
  • KLXE 83.1M
  • CUE 91.9M
  • IPO Year
  • KLXE N/A
  • CUE 2018
  • Fundamental
  • Price
  • KLXE $4.71
  • CUE $1.49
  • Analyst Decision
  • KLXE Hold
  • CUE Strong Buy
  • Analyst Count
  • KLXE 1
  • CUE 5
  • Target Price
  • KLXE $4.50
  • CUE $5.00
  • AVG Volume (30 Days)
  • KLXE 178.5K
  • CUE 254.0K
  • Earning Date
  • KLXE 03-05-2025
  • CUE 03-10-2025
  • Dividend Yield
  • KLXE N/A
  • CUE N/A
  • EPS Growth
  • KLXE N/A
  • CUE N/A
  • EPS
  • KLXE N/A
  • CUE N/A
  • Revenue
  • KLXE $738,000,000.00
  • CUE $9,532,000.00
  • Revenue This Year
  • KLXE N/A
  • CUE $73.11
  • Revenue Next Year
  • KLXE $4.79
  • CUE $11.02
  • P/E Ratio
  • KLXE N/A
  • CUE N/A
  • Revenue Growth
  • KLXE N/A
  • CUE 149.53
  • 52 Week Low
  • KLXE $4.18
  • CUE $0.45
  • 52 Week High
  • KLXE $9.48
  • CUE $2.37
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 39.05
  • CUE 58.61
  • Support Level
  • KLXE $4.51
  • CUE $1.22
  • Resistance Level
  • KLXE $5.12
  • CUE $1.50
  • Average True Range (ATR)
  • KLXE 0.36
  • CUE 0.12
  • MACD
  • KLXE -0.09
  • CUE 0.00
  • Stochastic Oscillator
  • KLXE 12.12
  • CUE 96.67

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

Share on Social Networks: